Voyager Therapeutics, Inc. (VYGR)
Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis (ALS), VY-HTT01 for Huntington's disease, and VY-FXN01 for Friedreich's ataxia. Additionally, Voyager is pursuing a Tau program aimed at various tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, alongside initiatives for spinal muscular atrophy. To advance its gene therapy product pipeline, the company has forged strategic collaboration and licensing agreements with key industry players such as Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. These partnerships cover the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and maintains its corporate headquarters in Cambridge, Massachusetts.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Voyager Therapeutics, Inc.
No splits on record
Nothing in VYGR's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Revenue | $40.37M | $80M | $250.01M | $40.91M | $37.41M | $171.13M | $104.39M | $7.62M | $10.13M | $14.22M | $17.33M | $0 | $0 |
| YoY Growth | -49.5% | -68.0% | 511.2% | 9.3% | -78.1% | 63.9% | 1270.1% | -24.8% | -28.7% | -18.0% | - | - | - |
| Cost of Revenue | $132.27M | $0 | $92.17M | $55.76M | $73.79M | $108.75M | $119.73M | $64.91M | $62.26M | $42.25M | $27.68M | $8.9M | $4.63M |
| Gross Profit | -$91.9M | $80M | $157.84M | -$14.86M | -$36.37M | $62.38M | -$15.34M | -$57.29M | -$52.13M | -$28.03M | -$10.35M | -$8.9M | -$4.63M |
| Gross Margin | -227.6% | 100.0% | 63.1% | -36.3% | -97.2% | 36.4% | -14.7% | -751.9% | -514.3% | -197.1% | -59.7% | - | - |
| Research and Development | $134.67M | $127.37M | $92.17M | $60.76M | $73.79M | $108.75M | $119.73M | $64.91M | $62.26M | $42.25M | $27.68M | $8.9M | $4.63M |
| Selling, General, and Administrative | $36.44M | $35.92M | $35.82M | $30.98M | $37.25M | $34.99M | $36.34M | $33.81M | $19.74M | $13.27M | $9.91M | $5.47M | $2.9M |
| Other | -$131.17M | $0 | -$92.17M | -$55.76M | -$73.79M | -$108.75M | -$119.73M | $2.63M | $1.17M | $1.16M | -$9.42M | $0 | $0 |
| Total Operating Expenses | $39.94M | $163.29M | $35.82M | $35.98M | $37.25M | $34.99M | $36.34M | $98.71M | $82M | $55.52M | $37.59M | $14.37M | $2.9M |
| Operating Income (EBIT) | -$131.84M | -$83.29M | $122.01M | -$50.84M | -$73.62M | $27.38M | -$51.68M | -$91.09M | -$71.86M | -$41.3M | -$20.25M | -$14.37M | -$7.53M |
| Operating Margin | -326.6% | -104.1% | 48.8% | -124.3% | -196.8% | 16.0% | -49.5% | -1195.6% | -709.1% | -290.4% | -116.8% | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $976K | $332K | $0 | $0 |
| Interest Income | $10.62M | $18.33M | $11.72M | $1.79M | $0 | $1.66M | $6.46M | $3.31M | $1.23M | $0 | $0 | $0 | $134K |
| Other Income (Expense) | $12.27M | $18.95M | $11.72M | $4.45M | $2.42M | $9.36M | $8.08M | $2.63M | $1.17M | $1.16M | -$9.42M | -$1.95M | -$134K |
| Income Before Tax (EBT) | -$119.58M | -$64.34M | $133.74M | -$46.39M | -$71.2M | $36.74M | -$43.6M | -$88.47M | -$70.7M | -$40.14M | -$29.67M | -$16.32M | -$7.67M |
| Income Tax Expense | $144K | $665K | $1.41M | $16K | $0 | $0 | $0 | -$180K | $0 | $52K | $0 | $0 | $0 |
| Net Income | -$119.72M | -$65M | $132.33M | -$46.41M | -$71.2M | $36.74M | -$43.6M | -$88.29M | -$70.7M | -$40.19M | -$29.67M | -$16.32M | -$7.67M |
| Net Income Margin | -296.5% | -81.3% | 52.9% | -113.4% | -190.3% | 21.5% | -41.8% | -1158.8% | -697.6% | -282.7% | -171.2% | - | - |
| Supplementary Data | |||||||||||||
| EPS | -2.04 | -1.13 | 3.08 | -1.21 | -1.75 | 0.99 | -1.14 | -2.75 | -2.64 | -1.59 | -7.08 | -1.11 | -16.55 |
| Diluted EPS | -2.04 | -1.13 | 2.97 | -1.21 | -1.75 | 0.98 | -1.14 | -2.75 | -2.64 | -1.59 | -7.08 | -1.11 | -16.55 |
| Weighted Average OS | 58.69M | 57.67M | 43.02M | 38.36M | 37.67M | 37.13M | 35.90M | 32.07M | 26.80M | 25.30M | 4.19M | 14.71M | 463,137 |
| EBITDA | -$115.52M | -$59.61M | $138.18M | -$39.65M | -$66.03M | $31.2M | -$48.91M | -$88.98M | -$70.27M | -$40.69M | -$19.65M | -$14.18M | $0 |
| EBITDA Margin | -286.1% | -74.5% | 55.3% | -96.9% | -176.5% | 18.2% | -46.9% | -1167.8% | -693.3% | -286.1% | -113.4% | - | - |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $65.3M | $71.37M | $68.8M | $98.96M | $117.43M | $104.44M | $86.04M | $46.86M | $31.53M | $36.64M | $31.31M | $7.04M | $135K |
| Short-Term Investments | $131.15M | $195.32M | $162.07M | $19.89M | $15.11M | $76.7M | $195.49M | $108.95M | $137.52M | $137.78M | $163.03M | $0 | $0 |
| Cash and Short-Term Investments | $196.45M | $266.68M | $230.88M | $118.85M | $132.54M | $181.14M | $281.53M | $155.81M | $169.05M | $174.42M | $224.34M | $7.04M | $135K |
| Accounts Receivable | $1.76M | $4.49M | $84.45M | $639K | $748K | $8.01M | $18.7M | $201K | $0 | $2.3M | $411K | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $2.2M | $5.11M | $1.85M | $1.52M | -$29.24M | $0 | $0 |
| Other Current Assets | $4.48M | $2.87M | $2.63M | $4.23M | $1.7M | $7.16M | $1.95M | $1.36M | $2.22M | $430K | $382K | $1.3M | $0 |
| Total Current Assets | $202.69M | $276.81M | $319.68M | $124.5M | $136.7M | $197.77M | $304.66M | $162.48M | $171.79M | $178.79M | $195.89M | $8.36M | $135K |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $41.61M | $47.66M | $30M | $33.34M | $55.38M | $61.5M | $46.46M | $12.77M | $10.28M | $7.89M | $3.23M | $2.8M | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $65.7M | $0 | $0 | $0 | $0 | $1.92M | $628K | $1.1M | $1.36M | $30.01M | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $7.98M | $2.87M | $1.59M | $1.51M | $1.78M | $2.32M | $1.72M | $1.15M | $1.3M | $1.53M | $321K | $335K | $14K |
| Total Long-Term Assets | $49.59M | $116.24M | $31.6M | $34.86M | $57.16M | $63.81M | $50.1M | $14.55M | $12.69M | $10.78M | $33.56M | $3.14M | $14K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $252.28M | $393.05M | $351.28M | $159.36M | $193.85M | $261.58M | $354.76M | $177.03M | $184.48M | $189.57M | $229.46M | $11.5M | $149K |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $5.01M | $4M | $1.6M | $2.57M | $574K | $634K | $4.07M | $1.04M | $1.02M | $550K | $612K | $1.55M | $950K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.93M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $1.59M | $24.39M | $42.88M | $59.38M | $33.89M | $0 | $47.23M | $20.85M | $3.38M | $6.76M | $19.59M | $0 | $0 |
| Other Current Liabilities | $9.09M | $6.75M | $6.61M | $4.56M | $5.02M | $7.73M | $15.78M | $6.01M | $8.11M | $4.09M | $2.39M | $552K | $15K |
| Total Current Liabilities | $26.54M | $49.79M | $64.51M | $72.59M | $50.98M | $26.77M | $76.01M | $31.67M | $15.9M | $13.8M | $23.93M | $2.47M | $3.98M |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6.3M | $0 |
| Long-Term Unearned Revenue | $0 | $6M | $32.36M | $6.45M | $8.21M | $0 | $194.49M | $113.05M | $31.56M | $41.58M | $54.98M | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | -$47.23M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $1M | $1M | $1M | $1M | $1M | $37.09M | $1M | $6.71M | $6.35M | $5.02M | $1.06M | $1.57M | $0 |
| Total Long-Term Liabilities | $29.66M | $43.5M | $50.45M | $27.75M | $47.82M | $80.5M | $179.24M | $98.91M | $34.53M | $39.84M | $36.45M | $7.87M | $3.88M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$3.88M |
| Total Liabilities | $56.2M | $93.29M | $114.96M | $100.34M | $98.8M | $107.26M | $255.25M | $130.58M | $50.43M | $53.64M | $60.38M | $10.35M | $3.98M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $21.98M | $0 |
| Common Stock | $59K | $55K | $44K | $38K | $38K | $37K | $37K | $32K | $32K | $26K | $25K | $1K | $0 |
| Retained Earnings | -$445.9M | -$326.18M | -$261.18M | -$393.51M | -$347.1M | -$275.91M | -$312.65M | -$269.05M | -$160.71M | -$90.02M | -$49.82M | -$20.83M | -$3.83M |
| Comprehensive Income & Other | $32K | -$407K | -$48K | -$219K | -$138K | -$134K | -$104K | -$133K | -$287K | -$52K | -$251K | -$21.98M | $0 |
| Other Stockholders' Equity | $641.93M | $625.89M | $497.46M | $452.49M | $442.12M | $430.19M | $412.12M | $315.46M | $294.73M | $225.91M | $218.87M | $21.98M | $0 |
| Total Equity | $196.08M | $299.76M | $236.32M | $59.02M | $95.06M | $154.32M | $99.51M | $46.45M | $134.05M | $135.92M | $169.07M | $1.15M | -$3.83M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $252.28M | $393.05M | $351.28M | $159.36M | $193.85M | $261.58M | $354.76M | $177.03M | $184.48M | $189.57M | $229.46M | $11.5M | $149K |
| Supplementary Data | |||||||||||||
| Total Debt | $36.5M | $43.73M | $20.29M | $23.13M | $44.18M | $47.61M | $34.17M | $0 | $0 | $0 | $0 | $6.3M | $2.93M |
| Net Debt | -$28.8M | -$27.64M | -$48.51M | -$75.83M | -$73.25M | -$56.83M | -$51.87M | -$46.86M | -$31.53M | -$36.64M | -$31.31M | -$730K | $2.79M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Operating Activities | |||||||||||||
| Net Income | -$119.72M | -$65M | $132.33M | -$46.41M | -$71.2M | $36.74M | -$43.6M | -$88.29M | -$70.7M | -$40.19M | -$29.67M | -$16.32M | -$7.67M |
| Depreciation & Amortization | $4.06M | $4.73M | $4.44M | $6.19M | $5.17M | $3.82M | $2.77M | $2.12M | $1.59M | $612K | $600K | $184K | $7.53M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$2.16M | -$24K | $696K | $452K | $0 | $0 |
| Stock-Based Compensation | $14.79M | $14.79M | $11.15M | $9.34M | $11.32M | $14.93M | $15.64M | $15.71M | $9.24M | $6.31M | $4.03M | $425K | $0 |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | $268K | $81.31M | -$83.23M | $475K | $7.28M | $10.48M | -$18.5M | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $1.02M | $2.39M | -$962K | $1.99M | -$60K | -$3.44M | $2.6M | -$282K | $470K | -$62K | -$942K | $604K | $0 |
| Other Working Capital | -$30.05M | -$48.84M | $17.64M | $18M | -$3.93M | -$151.59M | $94.34M | $55.66M | -$2.6M | -$12.79M | $57.08M | -$127K | $182K |
| Total Working Capital Change | -$28.76M | $34.86M | -$66.56M | $20.47M | $3.29M | -$144.54M | $78.44M | $55.38M | -$2.13M | -$12.85M | $56.14M | $477K | $182K |
| Other Non-Cash Items | -$2.83M | -$4.68M | -$3.45M | -$2.11M | -$2.11M | -$7.67M | -$4.58M | $1.36M | $674K | $2.94M | $9.75M | $3.31M | -$5.5M |
| Net Cash from Operating | -$132.47M | -$15.31M | $77.92M | -$12.51M | -$53.52M | -$96.72M | $48.67M | -$15.89M | -$61.35M | -$42.48M | $41.3M | -$11.92M | -$5.45M |
| Investing Activities | |||||||||||||
| Capital Expenditures | -$2.6M | -$3.52M | -$3.26M | -$2.49M | -$1.61M | -$12.1M | -$7.72M | -$4.3M | -$3.98M | -$5.03M | -$1.03M | -$2.99M | $0 |
| Acquisitions | $0 | $0 | $138.39M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$133.93M | -$465.69M | -$223.97M | -$54.85M | -$15.12M | -$70.4M | -$494.23M | -$333.23M | -$147.3M | -$112.35M | -$220.4M | $0 | $0 |
| Sales of Investments | $261.97M | $374.35M | $85.58M | $50M | $82.63M | $195.5M | $411.3M | $364M | $147.6M | $165.1M | $26.66M | $0 | $0 |
| Other Investing Activities | $0 | $0 | -$138.39M | $0 | $0 | $0 | $172K | $30.77M | $304K | -$421K | -$193.74M | -$314K | $0 |
| Net Cash from Investing | $125.45M | -$94.86M | -$141.64M | -$7.34M | $65.91M | $113M | -$90.48M | $26.47M | -$3.68M | $47.3M | -$194.77M | -$3.3M | $0 |
| Financing Activities | |||||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $816K | $114.02M | $33.65M | $1.11M | $612K | $0 | $77.62M | $0 | $57.99M | $0 | $104.78M | $80K | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $860K | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | $0 | $3.16M | $3.38M | $4.75M | $1.93M | $514K | -$31.81M | $0 | $5.72M |
| Net Cash from Financing | $816K | $114.02M | $33.65M | $1.11M | $612K | $3.16M | $80.99M | $4.75M | $59.92M | $514K | $177.74M | $22.12M | $5.72M |
| Forex Effect | $0 | $0 | $0 | $264K | $0 | -$1.04M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$6.21M | $3.85M | -$30.08M | -$18.47M | $12.99M | $18.4M | $39.18M | $15.33M | -$5.11M | $5.33M | $24.27M | $6.9M | $270K |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | -$132.47M | -$15.31M | $77.92M | -$12.51M | -$53.52M | -$96.72M | $48.67M | -$15.89M | -$61.35M | -$42.48M | $41.3M | -$11.92M | -$5.45M |
| Capital Expenditure | -$2.6M | -$3.52M | -$3.26M | -$2.49M | -$1.61M | -$12.1M | -$7.72M | -$4.3M | -$3.98M | -$5.03M | -$1.03M | -$2.99M | $0 |
| Free Cash Flow | -$135.06M | -$18.83M | $74.66M | -$15M | -$55.13M | -$108.81M | $40.95M | -$20.19M | -$65.33M | -$47.51M | $40.27M | -$14.91M | -$5.45M |
| Cash at Beginning | $74.24M | $70.39M | $100.47M | $117.43M | $104.44M | $86.04M | $47.59M | $32.27M | $36.64M | $31.31M | $7.04M | $135K | $0 |
| Cash at End | $68.04M | $74.24M | $70.39M | $98.96M | $117.43M | $104.44M | $86.78M | $47.59M | $31.53M | $36.64M | $31.31M | $7.04M | $270K |